Biotest uses microbial management to fight bioterrorism

Biotest Laboratories and president Gregg Mosley have created a system for managing microbes based on the principles of Evariology, which allows tracking of problematic organisms for medical manufacturers. It is a risk management process involving proactive bioburden monitoring devices and the production environment, allowing identification and prevention of the root causes of contamination.

‘We envision application of these same principles to bioterrorism in order that they can be used to identify various attack organisms or toxins and potentially predict what biological may be used by terrorists and where such an attack could occur,’ said Mosley.

Working with BioDefense Corp of Boston, Massachusetts and the Bioterrorism Response Laboratory of the State of Massachusetts, Biotest has developed a challenge pack that can test the effects of numerous types of sterilisation processes at the same time. It contains proprietary biological and chemical indicators more resistant than the typical pathogens used for bioterrorism to ensure inactivation of potential attack organisms.

‘Anthrax attacks – either as a hoax, or the very deadly real thing – are a continual headache to the security community, because this dangerous pathogen is easily sent through the mail, said John Meyer, president of BioDefense Corporation.

‘MailDefender III is the only equipment that actually kills anthrax, smallpox, SARS, avian flu, and many other dangerous substances in the customer's office.’

BioDefense has secured a patent for the MailDefender III technology and has completed independent testing from multiple laboratories under government supervision.

Contact T +1 763 785 2414 www.biotestlabs.com bio-def.com